Skip to content

Gross Profit at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$2.15B+15.7%
AVT
AvantorAVTR
$500.7M-6.4%
Dow logo
DowDOW
$640M-4.6%
AptarGroup logo
AptarGroupATR
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD

Other financials

Income statement

See full
Revenue$844.9M+21.0%
Operating income$177.1M+65.5%
Net income$138.8M+54.6%
EPS (diluted)$1.92+56.1%

Balance sheet

See full
Cash & equivalents$521.4M+29.0%
Total debt$321.0M+4.4%
Total equity$3.0B+11.5%
Total assets$4.1B+13.6%

Cash flow

See full
Operating cash flow$89.9M-30.5%
CapEx$42.7M-40.1%
Free cash flow$47.2M-18.8%

Valuation

See full
Market cap$25.36B+64.2%
Enterprise value$25.16B+65.1%
P/E46.7×+15.1×
P/S7.9×+2.7×

Profitability

See full
Gross margin36.3%+1.7pp
Operating margin20.3%+1.2pp
Net margin16.8%+0.7pp
FCF margin14.2%+3.6pp

Returns & leverage

See full
Return on equity19.1%+1.7pp
Debt / equity0.1×0.0×
Current ratio2.7×-0.1×

Where this comes from

Calculated from West Pharmaceutical Services’s reported figures.

The official record: West Pharmaceutical Services’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about West Pharmaceutical Services's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is West Pharmaceutical Services's gross profit?
West Pharmaceutical Services (WST) reported gross profit of $296.4M in Q1 2026.
How has West Pharmaceutical Services's gross profit changed year-over-year?
West Pharmaceutical Services's gross profit increased by 27.8% year-over-year, from $231.9M to $296.4M.
What is the long-term trend for West Pharmaceutical Services's gross profit?
Over 4 years (2021 to 2025), West Pharmaceutical Services's gross profit has grown at a -1.6% compound annual growth rate (CAGR), from $1.18B to $1.1B.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.